SCHEMBL6689612

SCHEMBL6689612

C[C@H](O)C(O)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.65
LMNA P02545 3/20 0.65
ADRA2C P18825 2/20 0.65
ADRA2A P08913 1/20 0.65
HIF1A Q16665 1/20 0.65
ALDH1A1 P00352 3/20 0.62
TSHR P16473 2/20 0.60
CHRM2 P08172 1/20 0.60
ADRA1A P35348 1/20 0.60
RGS12 O14924 1/20 0.60
GLA P06280 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
CYP2C9 P11712 1/20 0.60
PKM P14618 1/20 0.60
ALOX15 P16050 1/20 0.60
ALOX12 P18054 1/20 0.60
NFKB1 P19838 1/20 0.60
HTR2A P28223 1/20 0.60
CYP2C19 P33261 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL517001 1.00 KDM4E (0.65) KDM4ELMNAADRA2CADRA2AHIF1A
SCHEMBL25159 1.00 KDM4E (0.65) KDM4ELMNAADRA2CADRA2AHIF1A
SCHEMBL6543382 1.00 KDM4E (0.65) KDM4ELMNAADRA2CADRA2AHIF1A
SCHEMBL28117044 1.00 KDM4E (0.65) KDM4ELMNAADRA2CADRA2AHIF1A
SCHEMBL6483432 1.00 KDM4E (0.65) KDM4ELMNAADRA2CADRA2AHIF1A
SCHEMBL5353745 1.00 KDM4E (0.65) KDM4ELMNAADRA2CADRA2AHIF1A
SCHEMBL1954690 1.00 KDM4E (0.65) KDM4ELMNAADRA2CADRA2AHIF1A
SCHEMBL12761516 1.00 KDM4E (0.65) KDM4ELMNAADRA2CADRA2AHIF1A
Bicarbonate SCHEMBL4901524 0.93 LMNA (0.58) KDM4ELMNAADRA2CADRA2AHIF1A
SCHEMBL28002029 0.93 KDM4E (0.58) KDM4ELMNAADRA2CADRA2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104640842-B Aplysiatoxin-10 derivant, its preparation method and comprise its anticancer pharmaceutical composition CELLTRION INC. (KR) 2016-11-30 CN disclosed
EP-1468101-A1 PROCESS FOR PREPARING CHIRAL AROMATIC ALPHA-HYDROXY KETONES USING 2-HYDROXY-3-OXOACID SYNTHASE BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) 2004-10-20 EP disclosed
WO-2003062436-A1 PROCESS FOR PREPARING CHIRAL AROMATIC α-HYDROXY KETONES USING 2-HYDROXY-3-OXOACID SYNTHASE BEN-GURION UNIVERSITY OF THE NEGEV (IL) 2003-07-31 WO disclosed